I'm LongbridgeAI, I can summarize articles.Sinomab Bio (3681.HK) fell nearly 5% in Hong Kong trading to HK$0.9550, hitting a 52-week low intraday.
The stock is down 10.75% over the past ten sessions and down 28.73% year to date. It sits 56.39% below its 52-week high of HK$2.190. Volume was 0.31 times its average.
The Hang Seng Index is down 3.48% over the past five sessions and down 7.80% year to date.
The biotechnology industry index fell 3.0% over the same period, in line with the stock's move.
Based on public media reports. AI-generated; not investment advice.
